Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry

Annals of Intensive Care

Volumn 6, Issue 1, 2016, Pages

  Cutuli, Salvatore Lucio ^a   Artigas, Antonio ^b   Fumagalli, Roberto ^c   Monti, Gianpaola ^c   Ranieri, Vito Marco ^d   Ronco, Claudio ^e   Antonelli, Massimo ^a   The EUPHAS 2 Collaborative Group, ^f   Maviglia, Riccardo ^f   Cicconi, Sandra ^f   Silvestri, Davide ^f   Bello, Giuseppe ^f   Brendolan, Alessandra ^f   Nalesso, Federico ^f   Villa, Gianluca ^f   Piccinni, Pasquale ^f   Martin, Erica ^f   Cantaluppi, Vincenzo ^f   Vesconi, Sergio ^f   Casella, Giampaolo ^f   Fasanella, Egidio ^f   Debitonto, Michele ^f   Monza, Gianmario ^f   Blasetti, Angelo ^f   Coletta, Rosaria ^f   D’Ambrosio, Michele ^f   Cinnella, Gilda ^f   Murino, Patrizia ^f   Piscitelli, Eugenio ^f   Centonze, Gaetano ^f   Cucurachi, Marco ^f   Altieri, Giuseppe ^f   Leonardo, Vincenzo ^f   Idra, Anna Sara ^f   Del Rosso, Goffredo ^f   Polidoro, Maria ^f   Stigliano, Nicola ^f   Pittella, Giuseppe ^f   Paternoster, Gianluca ^f   Pulito, Giuseppe ^f   Puscio, Daniela ^f   Cingolani, Diego ^f   Falzetti, Gabriele ^f   Vecchiarelli, Pietro ^f   Giunta, Francesco ^f   Forfori, Francesco ^f   Castiglione, Giacomo ^f   Greco, Stefano ^f   Capra, Carlo ^f   Crema, Luciano ^f   Tamayo, Leonor ^f   Urbano, Cristina ^f   Pezza, Brunello ^f   Zarrillo, Nadia ^f   Di Monaco, Pasquale ^f   Climaco, Giuseppe ^f   De Negri, Pasquale ^f   Modano, Pasqualina ^f   Pagliarulo, Riccardo ^f   Petrillo, Claudio ^f   Stripoli, Tania ^f   Oggioni, Roberto ^f   Campiglia, Laura ^f   Valletta, Anna Rita ^f   Lugano, Manuela ^f   Milella, Domenico ^f   Micucci, Laura ^f   Reist, Ursula ^f   Ensner, Rolf ^f   Gianbarba, Christian ^f   Brander, Lukas ^f   Paul, Rajib ^f   Crawla, Rajesh ^f   Jasujia, Sanjeev ^f   Pande, Rajesh ^f   Dileep, Pratibha ^f   Sundar, Sankaran ^f   Ganesan, Raju ^f   Dewan, Sandeep ^f   Nangia, Vivek ^f   Mani, Raj Kumar ^f   Singh, Omender ^f   Sathe, Pracee ^f   Sachin, Gupta ^f   D’Costa, Pradeep M ^f   Srivanas, Samavedam ^f   Singh, Yogendra Pal ^f   Doi, Kent ^f   Taki, Fumika ^f   Roca, Ricard Ferrer ^f   Medina, Eduardo Romay ^f   Gernacho, Josè ^f   Martí, Francisco ^f   Martinez Ruiz, Alberto ^f   Martinez Sagasti, Fernando ^f   Crespo, Rafael Zaragoza ^f   Torti, Paola ^f   Terzi, Valeria ^f   more..

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e SAN BORTOLO HOSPITAL   (Italy)

^f NONE

Author keywords

EAA; Extracorporeal endotoxin removal; Infection; Polymyxin B hemoperfusion; Sepsis; Septic shock

Indexed keywords

POLYMYXIN B;

ABDOMINAL INFECTION; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ASIAN; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CARDIOVASCULAR RESPONSE; CLINICAL PRACTICE; CONTINUOUS INFUSION; DISEASE SEVERITY; ENDOTOXEMIA; EUROPEAN; FEMALE; GRAM NEGATIVE SEPSIS; HOSPITAL ADMISSION; HOSPITAL MORTALITY; HUMAN; HYPOTENSION; INTENSIVE CARE; KIDNEY FUNCTION; LENGTH OF STAY; LIVER FUNCTION; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FUNCTION; RETROSPECTIVE STUDY; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SURVIVAL RATE; SURVIVAL TIME; TACHYCARDIA; TREATMENT OUTCOME;

EID: 84981719229     PISSN: None     EISSN: 21105820     Source Type: Journal    
DOI: 10.1186/s13613-016-0178-9     Document Type: Article

References (32)

1. Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial. 2003;7:108–14.
2. Opal SM, Gluck T. Endotoxin as a drug target. Crit Care Med. 2003;31:S57–64.
3. Kellum JA. A targeted extracorporeal therapy for endotoxemia: the time has come. Crit Care. 2007;11:137.
4. Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, Opal S, Abraham E, Brett SJ, Smith T, Mehta S, Derzko A, Romaschin A. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis. 2004;190:527–34.
5. Perego AF, Morabito S, Graziani G, Casella GP, Parodi O. Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis. G Ital Nefrol. 2006;23(Suppl 36):S94–102.
6. Nakamura T, Ebihara I, Shoji H, Ushiyama C, Suzuki S, Koide H. Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble P-selectin, platelet factor 4 and beta-thromboglobulin. Inflamm Res. 1999;48:171–5.
7. Cantaluppi V, Assenzio B, Pasero D, Romanazzi GM, Pacitti A, Lanfranco G, Puntorieri V, Martin EL, Mascia L, Monti G, Casella G, Segoloni GP, Camussi G, Ranieri VM. Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med. 2008;34:1638–45.
8. Kushi H, Miki T, Okamaoto K, Nakahara J, Saito T, Tanjoh K. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care. 2005;9:R653–61.
9. Suzuki H, Nemoto H, Nakamoto H, Okada H, Sugahara S, Kanno Y, Moriwaki K. Continuous hemodiafiltration with Polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure. Ther Apher. 2002;6:234–40.
10. Uriu K, Osajima A, Hiroshige K, Watanabe H, Aibara K, Inada Y, Segawa K, Anai H, Takagi I, Ito A, Kamochi M, Kaizu K. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock. Am J Kidney Dis. 2002;39:937–47.
11. Nemoto H, Nakamoto H, Okada H, Sugahara S, Moriwaki K, Arai M, Kanno Y, Suzuki H. Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif. 2001;19:361–8.
12. Nakamura H, Matsuda K, Suzuki Y, Shoji H, Koide H. Polymyxin B-immobilized fiber hemoperfusion in patients with sepsis. Dial Transplant. 2003;32:602–7.
13. Ruberto F, Pugliese F, D’Alio A, Martelli S, Bruno K, Marcellino V, Summonti D, Celli P, Perrella S, Cappannoli A, Pietropaoli C, Tosi A, Diana B, Novelli G, Rossi M, Ginanni-Corradini S, Ferretti G, Berloco PB, Pietropaoli P. Clinical effects of direct hemoperfusion using a polymyxin-B immobilized column in solid organ transplanted patients with signs of severe sepsis and septic shock. A pilot study. Int J Artif Org. 2007;30:915–22.
14. Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V, Lentini P, Nalesso F, Ueno T, Ranieri VM, Ronco C. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care. 2007;11:R47.
15. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009;301:2445–52.
16. Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, Pottecher J, Joannes-Boyau O, Martin-Lefevre L, Jabaudon M, Mimoz O, Coudroy R, Ferrandiere M, Kipnis E, Vela C, Chevallier S, Mallat J, Robert R. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med. 2015;41(6):975–84.
17. Tsushima K, Kubo K, Yoshikawa S, Koizumi T, Yasuo M, Furuya S, Hora K. Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome. Ther Apher Dial. 2007;11(2):138–45.
18. Martin EL, Cruz DN, Monti G, Casella G, Vesconi S, Ranieri VM, Ronco C, Antonelli M. Endotoxin removal: how far from the evidence? The EUPHAS 2 Project. Contrib Nephrol. 2010;167:119–25.
19. Early Use of Polymyxin B Hemoperfusion in the Abdominal Sepsis 2 Collaborative Group. Polymyxin B hemoperfusion in clinical practice: the picture from an unbound collaborative registry. Blood Purif. 2014;37(Suppl 1):22–5.
20. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637.
21. Marshall JC, Walker PM, Foster DM, Harris D, Ribeiro M, Paice J, Romaschin AD, Derzko AN. Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Crit Care. 2002;6:342–8.
22. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–10.
23. Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286:1754–8.
24. Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med. 1999;25:686–96.
25. Jones AE, Trzeciak S, Kline JA. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med. 2009;37:1649–54.
26. Quenot JP, Binquet C, Kara F, Martinet O, Ganster F, Navellou JC, Castelain V, Barraud D, Cousson J, Louis G, Perez P, Kuteifan K, Noirot A, Badie J, Mezher C, Lessire H, Pavon A. The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study. Crit Care. 2013;17:R65.
27. Phua J, Koh Y, Du B, Tang YQ, Divatia JV, Tan CC, Gomersall CD, Faruq MO, Shrestha BR, Gia Binh N, Arabi YM, Salahuddin N, Wahyuprajitno B, Tu ML, Wahab AY, Hameed AA, Nishimura M, Procyshyn M, Chan YH. Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort study. BMJ. 2011;342:d3245.
28. Zhou F, Peng Z, Murugan R, Kellum JA. Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med. 2013;41:2209–20.
29. Iwagami M, Yasunaga H, Doi K, Horiguchi H, Fushimi K, Matsubara T, Yahagi N, Noiri E. Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: a propensity-matched analysis. Crit Care Med. 2014;42(5):1187–93.
30. Angus DC, Barnato AE, Bell D, Bellomo R, Chong CR, Coats TJ, Davies A, Delaney A, Harrison DA, Holdgate A, Howe B, Huang DT, Iwashyna T, Kellum JA, Peake SL, Pike F, Reade MC, Rowan KM, Singer M, Webb SA, Weissfeld LA, Yealy DM, Young JD. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive Care Med. 2015;41(9):1549–60.
31. Monti G, Terzi V, Calini A, Di Marco F, Cruz D, Pulici M, Brioschi P, Vesconi S, Fumagalli R, Casella G. Rescue therapy with polymyxin B hemoperfusion in high-dose vasopressor therapy refractory septic shock. Miner Anestesiol. 2015;81:516–25.
32. Klein DJ, Foster D, Schorr CA, Kazempour K, Walker PM, Dellinger RP. The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial. Trials. 2014;11(15):218. doi:10.1186/1745-6215-15-218.